Stock listing
NYSE:KG King Pharmaceuticals Inc Stock
Follow King Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NYSE:KG
$14.24 USD
Close on Feb 28, 2011 · No longer trades
- Lowest – highest close
- $6.13 – $65.25 USDSince Jun 26, 1998 · lowest Mar 6, 2009 · highest Dec 3, 1999
Delisted NYSE:KG no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NYSE:KG
- Asset type
- Stock
- Exchange
- NYSE
- Currency
- USD
King Pharmaceuticals Inc on 6ix
- Decks
- 1 deck · latest Jul 26, 2004
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2026 | Nov 6, 2026 | −1.0% |
| Quarter to Jun 30, 2026 | Aug 7, 2026 | −3.5% |
| Quarter to Mar 31, 2026 | May 8, 2026 | +4.6% |
| Quarter to Sep 30, 2025 | Nov 5, 2025 | −16.7% |
| Quarter to Mar 31, 2025 | May 12, 2025 | 0.0% |
| Quarter to Dec 31, 2024 | Mar 10, 2025 | +22.5% |
| Quarter to Sep 30, 2024 | Nov 12, 2024 | −9.3% |
| Quarter to Jun 30, 2024 | Aug 8, 2024 | +1.2% |
| Quarter to Mar 31, 2024 | May 9, 2024 | +1.9% |
| Quarter to Dec 31, 2023 | Mar 12, 2024 | +1.4% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2023 | Nov 8, 2023 | −6.6% |
| Quarter to Jun 30, 2023 | Aug 8, 2023 | −7.8% |
| Quarter to Mar 31, 2023 | May 9, 2023 | −8.9% |
| Quarter to Dec 31, 2022 | Mar 15, 2023 | −7.6% |
| Quarter to Sep 30, 2022 | Nov 9, 2022 | +9.9% |
| Quarter to Jun 30, 2022 | Aug 9, 2022 | +4.4% |
| Quarter to Mar 31, 2022 | May 10, 2022 | +9.3% |
| Quarter to Dec 31, 2021 | Mar 14, 2022 | +13.8% |
| Quarter to Sep 30, 2021 | Nov 9, 2021 | −9.1% |
| Quarter to Jun 30, 2021 | Aug 9, 2021 | −4.4% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (July 2004) | Merger or acquisition | 18 slides | Jul 26, 2004 |
Cap table
Built by 6ix from King Pharmaceuticals Inc’s releases
- Common shares
- 7,824,030
- Fully diluted
- 7,824,030
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 7,824,030 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 7,824,030 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Douglas E Giordano Other companies: Kardigan, Inc. (Director · Since at least Jun 17, 2026); Panacea Acquisition II Corp (Director · Apr 6, 2021 – Apr 6, 2021 · Past); Cerevel Therapeutics Holdings Inc (Director · Oct 27, 2020 – Aug 1, 2024 · Past); Viatris Inc. (Director · Aug 6, 2020 – Nov 16, 2020 · Past); ICU Medical, Inc. (Director · Feb 3, 2017 – Feb 3, 2017 · Past); Zoetis Inc. (Director · Jan 31, 2013 – Feb 6, 2013 · Past); Icagen Inc (Director · Sep 22, 2011 – Sep 22, 2011 · Past); Encysive Pharmaceuticals Inc (Director · Apr 3, 2008 – Apr 3, 2008 · Past) | Director · Jan 31, 2011 – Jan 31, 2011 · Past |
| Kevin S Crutchfield Other companies: Intrepid Potash, Inc (Chief Executive Officer, Director · Since at least Dec 2, 2024); Compass Minerals Intl Inc (President and CEO, Director · May 7, 2019 – Jan 17, 2024 · Past); Alpha Metallurgical Resources, Inc. (Chief Executive Officer, Director · Nov 9, 2018 – May 2, 2019 · Past); Rice Energy (Director · Jan 24, 2014 – Nov 6, 2014 · Past); Coeur Mining, Inc. (Director · May 14, 2013 – Feb 5, 2019 · Past); Alpha Natural Resources Inc (Chairman and CEO, Director · Dec 31, 2005 – Mar 13, 2015 · Past) | Director · Feb 8, 2010 – Jan 31, 2011 · Past |
| Brian A Markison Other companies: Organogenesis Holdings Inc. (Director · Oct 7, 2016 – Dec 10, 2018 · Past); Lantheus Holdings, Inc. (CEO, Director · Jun 24, 2015 – Mar 5, 2025 · Past); Alere Inc (Director · Aug 14, 2013 – Oct 3, 2017 · Past); Altimmune, Inc. (Director · Sep 22, 2011 – Dec 31, 2014 · Past); Immunomedics Inc (Director · Aug 24, 2006 – Nov 20, 2017 · Past) | President and CEO, Director · Mar 20, 2006 – Feb 28, 2011 · Past |
| Jeffrey Bailey Other companies: Aurinia Pharmaceuticals Inc (Board Director · Since at least Aug 18, 2023); BioDelivery Sciences International Inc (Chief Executive Officer, Director · Mar 9, 2020 – Mar 22, 2022 · Past); Rein Therapeutics, Inc. (Director · Mar 15, 2018 – Jun 17, 2022 · Past); Lantheus Holdings, Inc. (CEO and President, Director · Jun 24, 2015 – Aug 31, 2015 · Past); Landauer Inc (Director · Apr 17, 2015 – Oct 19, 2017 · Past) | Chief Commercial Officer · Aug 30, 2010 – Mar 1, 2011 · Past |
| Earnest W Deavenport Jr Other companies: Zep Inc (Director · Oct 31, 2007 – Nov 1, 2010 · Past); Regions Financial Corporation (Director · Nov 4, 2006 – Jan 15, 2010 · Past); Acuity Inc. (Director · Jan 12, 2006 – Aug 1, 2007 · Past); Amsouth Bancorporation (Director · Jan 3, 2006 – Nov 4, 2006 · Past) | Director · Apr 28, 2006 – Nov 11, 2010 · Past |
| Bryan Supran Other companies: Alnylam Pharmaceuticals, Inc. (Chief Legal Officer · Since at least Sep 15, 2025); Viatris Inc. (Director · Aug 6, 2020 – Nov 16, 2020 · Past); Icagen Inc (Director · Sep 22, 2011 – Sep 22, 2011 · Past) | Director · Jan 31, 2011 – Jan 31, 2011 · Past |
| Derace L Schaffer Other companies: Lantheus Holdings, Inc. (Director · Mar 4, 2016 – Mar 3, 2020 · Past); American Caresource Holdings Inc (Director · Jul 20, 2010 – Jun 14, 2012 · Past); Altimmune, Inc. (Director · May 17, 2010 – Dec 28, 2017 · Past) | Director · May 14, 2010 – Jan 31, 2011 · Past |
| Eric Carter Other companies: AEON Biopharma, Inc. (Board Member · Since at least Jul 21, 2023); Alder BioPharmaceuticals Inc (Interim Chief Medical Officer · Apr 23, 2018 – Apr 23, 2018 · Past); Adverum Biotechnologies Inc (Director · Sep 7, 2017 – Jun 23, 2020 · Past) | Chief Science Officer · Jan 24, 2007 – Mar 1, 2011 · Past |
| Kristin C. Peck Other companies: BlackRock, Inc. (Director · Since at least Sep 28, 2021); Zoetis Inc. (President and Chief Executive Officer · Since at least Jan 31, 2013); Pfizer, Inc. (Executive Vice President · Apr 1, 2010 – Oct 31, 2012 · Past) | Director · Jan 31, 2011 – Jan 31, 2011 · Past |
| Ted G Wood Other companies: Alpha Natural Resources Inc (Director · Jan 25, 2006 – May 17, 2012 · Past); POZEN Inc (Director · Jan 3, 2006 – Jan 3, 2006 · Past) | Director · Apr 28, 2006 – Feb 28, 2011 · Past |
All 21 people
| Person | Seat |
|---|---|
| Charles Moyer Other companies: Capitala Finance Corp (Director · Sep 24, 2013 – May 20, 2015 · Past) | Director · Apr 28, 2006 – Feb 28, 2011 · Past |
| Elizabeth M Greetham Other companies: Ligand Pharmaceuticals Incorporated (Director · Mar 1, 2007 – May 29, 2008 · Past) | Director · Apr 28, 2006 – Feb 28, 2011 · Past |
| James W Elrod Other companies: Tivity Health Inc (VP, General Counsel · Feb 21, 2011 – Mar 3, 2011 · Past) | Chief Legal Officer, A. Sec. · Feb 21, 2006 – Feb 15, 2011 · Past |
| Joseph Squicciarino Other companies: Zep Inc (Director · Sep 29, 2008 – Jun 26, 2015 · Past) | Chief Financial Officer · Dec 31, 2008 – Mar 1, 2011 · Past |
| Matthew Lepore Other companies: Air Products and Chemicals, Inc. (EVP & General Counsel · Since at least Aug 18, 2025) | Director · Jan 31, 2011 – Jan 31, 2011 · Past |
| Philip A Incarnati Other companies: Theragenics Corp (Director · May 9, 2006 – May 19, 2006 · Past) | Director · Nov 1, 2006 – Oct 7, 2010 · Past |
| D Gregory Rooker | Director · Jan 11, 2006 – Nov 29, 2010 · Past |
| Eric J Bruce | President, Animal Health · Mar 20, 2006 – Feb 28, 2011 · Past |
| James E Green | Exec Vice Pres Corp Affairs · Mar 20, 2006 – Mar 20, 2009 · Past |
| Philip M Pfeffer | Director · Apr 28, 2006 – Apr 28, 2006 · Past |
| Stephen J Andrzejewski | Chief Commercial Officer · Mar 20, 2006 – Mar 22, 2010 · Past |
Log in to ask 6ix AI your own questions about King Pharmaceuticals Inc.